Abstract
INTRODUCTION
As a strategy to reduce the drawbacks of many pharmaceutical formulations, polymers, liposomes and cyclodextrins (CDs) have been used as controlled or sustained release systems.
These modified release systems can provide a reduction of drug concentration or decrease in the dose administration per day. The CDs has attracted the attention not only in the pharmaceutical formulations but also in food and biological areas, because of their ability to form inclusion compounds (ICs) with guest molecules in solutions or solid-state [1] [2] [3] . Indeed, CDs have been used extensively in pharmaceutical formulations as solubilizers to enhance oral bioavailability [4] .
Cyclodextrins (CDs) are cyclic oligosaccharides consisting of six (α-CD), seven (β-CD), or eight (γ-CD) glucopyranose units in their structure [5] . Due to formation of α-1,4-glycosidic linkage, CDs are doughnut shaped molecules, possessing hollow cavities which can accommodate a variety of guests in aqueous solution and in the crystalline state by non-covalent interactions [6, 7] . The presence of hydroxyl groups on the exterior surface of CDs make them fairly polar while the interior of the cavity is relatively nonpolar. The slightly hydrophobic character of the inner cavity provides a driving force for hostguest complexation with similarly apolar guest molecules [7] .
The prediction of the behavior of guests such as drugs in CD solution is dependent on the complexation constant (also called the stability or formation constant) for the CD-guest complex, and the stoichiometry of complexation. Measurements of complexation induced chemical-shift displacements (up-or downfield) in nuclear magnetic resonance spectroscopy as a function of concentrations (NMR titrations) can be used to determine the complexation constant and changes in chemical shifts resulting from inclusion of the guest molecule in the CD cavity. Compared to other methods of equilibrium determinations, these methods have the advantage of providing several independent signals for the evaluation of stability constants [8] .
Fluorine ( 19 F) NMR has been used to demonstrate the complexation of natural β-CD with perfluorinated ends of telomeric polymers [9] [10] [11] and fluorinated amino acid derivatives [12] . Fluorine as a group is rare in natural compounds, but is a relatively common substitute in drugs. Some drugs have fluorine(s) in their structures, e.g., psychotropic drugs, synthetic steroidal hormones and new quinolone drugs. They are widely used clinically because the introduction of fluorine atom(s) into the drugs improves their pharmaceutical activities or induces new pharmaceutical activities [13] . This method is limited by the fact that a majority of drugs do not contain fluorine, but when it is applicable; 19F-NMR should have certain advantages over the more commonly applied proton ( 
EXPERIMENTAL Materials and reagents
Analytical grade, high-purity substances were used throughout this study. Racemic fluoxetine (as the hydrochloride salt) was obtained from Recordati, Spain. Citalopram hydrobromide was purchased from Ranboxy, India. Fluvoxamine maleate was obtained from Solvay-Duphar, Netherlands. These drug standards were used without any further purification. Deuterium oxide (> 99.9 %) was supplied by Merck (Darmstadt, Germany). α-and β-Cyclodextrins were purchased from Fluka (Buchs, Switzerland). Methylated α-cyclodextrin (M-α-CD), tetramino derivative of methylated α-cyclodextrin, 6B,6C,6E,6F-tetramino-6B,6C,6E,6F -tetradeoxy -2A,2B,2C,2D,2E,2F,3A,3B,3C,3D,3E,3F,6A,6D-tetradeca-O-methylcyclomaltohe-xaose (TAM-α-CD) and diamino derivative of methylated α-cyclodextrin,6A,6D-diamino-6A,6D-dideoxy-2A, 2B,2C,2D,2E,2F,3A,3B,3C,3D,3E,3F,6B,6C,6E, 6F-hexadeca-O-methylcyclomalto-hexaose (DAM-α-CD) [14] were a gift of prof. Matt (Laboratoire de Chimie Inorganique et Catalyse, Université de Strasbourg, Strasbourg, France). 19 F-NMR spectra were recorded on a BRUKER DRX 500 AVANCE (11.7 T) spectrometer operating at 470.59 MHz 19 F observation frequency, equipped with a dedicated 5-mm QNP probehead and running XWIN-NMR 2.6 software using 500 µl of samples. 
Instrumentation

All
RESULTS
19
F NMR spectra of fluoxetine hydrochloride were obtained in aqueous solution in the absence and presence of increasing amount of different cyclodextrins. Experiments were performed with solutions containing 0.001 M fluoxetine and having different concentrations of CDs (α-CD, M-α-CD, DAM-α-CD, TAM-α-CD and β-CD). All the spectra contained one set of resonances suggesting a fast equilibrium between the free and complexed forms of the drug, on the NMR time scale.
Typically, the changes observed in the successive 19 F NMR spectra of fluoxetine upon addition of M-α-CD and DAM-α-CD is shown in Figure 2 Figure 4 and the calculated log K f values for each of the fluoxetine enantiomers are given in Table 1 . As it can be observed in Figure 4 , a good agreement between the experimental and calculated chemical shifts supports the formation of a complex with 1:1 stoichiometry between drug and CD.
In the present work, it also investigated the complexation of citalopram hydrobromide and fluvoxamine maleate with α-CD, M-α-CD, DAM-α-CD and β-CD. Experiments were performed with solutions containing 0.001 M drug and having different concentrations of CDs. The K f values were evaluated by fitting the chemical shift-mole ratio data to Eq 1 using the KINFIT program for a 1:1 complex model. The resulting log K f values are included in Table 1 .
The results from the 19 F-NMR study show that the fluvoxamine phenyl group with the -CF 3 substitution remains outside the α-CD cavity, as it does not undergo any significant spectral changes.
In order to gain further insights into the inclusion process, molecular modeling (MM) calculations was used to predict the geometry of the complex of fluvoxamine and β-CD. Molecular modeling studies were performed in vacuum phase employing the empirical force fields and semiempirical quantum theory using the AM1 Hamiltonian. The initial geometry of fluvoxamine was obtained using a full geometry optimization at the level of B3LYP/6-31 + + G** and the initial geometry of β-CD was obtained using a full geometry optimization at the level of AM1 based on the available crystallography data [16] . The initial docked structure of the inclusion complex of fluvoxamine and β-CD was obtained using the simulated annealing method, with a rigid geometry and fixed partial charges for the individual molecules. The calculations were performed by HyperChem [17] and Gaussian 98 packages of program [18] . The minimum energy structure of the complex obtained is shown in Figure 5 .
DISCUSSION
In the 19 F-NMR spectra, fluoxetine has one strong singlet at -61.3 ppm. Fluoxetine is a racemic mixture and addition of different CDs (except α-CD) resulted in separation of the enantiomers in the 19 F-NMR spectra, with different chemical shifts for either enantiomer. In fact, because of the formation of diastereomeric complexes between the CDs and the fluoxetine enantiomers, a doublet set of more or less shifted signals can be seen for the diastereomers. Thus, the presence of two enantiomers can be demonstrated simply by the addition of CD, and equal size of the peaks confirmed that the enantiomers were present in equimolar quantities.
The data given in Table 1 clearly indicate the formation constants are almost the same for both enantiomers of fluoxetine with CDs, showing that the extent of inclusion of the guest into the CD cavity is the similar for two enantiomers. 19F-NMR spectroscopy of mixtures of fluoxetine hydrochloride and different CDs revealed the existence of inclusion complexes formed by the penetration of CF3-substituted ring into the CD cavity, in analogy to previously reported findings for complex of fluoxetine with β-CD [3, 7] .
A primary criterion for the inclusion of a guest molecule within the host's cavity is obviously its size and then other factors such as strict fit, van der Waals' interactions, hydrogen bonding and so on [19, 20] . As can be seen in the Table 1 , the Kf values obtained for the complexes of fluoxetine and fluvoxamine with β-CD is somewhat higher than the other cyclodextrins. It is most possibly due to the consonance between the size of β-CD cavity and the size of included group inside cavity.
It is interesting to note that, methylated derivatives of α-CD possess stronger ability for the complexation than the parent α-CD. This probably reflects the ability of flexible permethylated CDs to better adapt their shape to that of the included guest molecules. Chemical modification [21] , notably permethylation, often renders the macrocyclic structure much more flexible as a result of interglucose O(2)n...O(3)n-1 hydrogen bond breaking which can lead to significant shape modification of the torus [22, 23] . It is pointed out that per-2,3,6-methylated CDs are more water soluble at room temperature than their natural analogues and retain inclusion properties to a certain extent [24] . Furthermore, a comparison between the binding constant values of resulting 1:1 complexes of fluoxetine molecule with modified α-CDs show that the structure of B,C,E,F-tetrafunctionalized methylated α-CD has become more rigid than A,D-difunctionalized methylated α-CD.
The Kf values obtained for the complex of citalopram with different CDs (Table 1) reveal the permethylation of cyclodextrins enhance their complex forming ability. As mentioned above, it can be explained by changes in the shape of the cyclodextrin cavity to accommodate the guest molecule.
The molecular modeling data suggest that fluvoxamine/β-CD inclusion complexes have a 1:1 stoichiometry and that the CF3-substituted ring of fluvoxamine is embedded in the cavity of β-CD ( Figure 5) . Therefore, the results reported show a good agreement between MM calculation and experimental data (NMR data).
CONCLUSION
19
F-NMR titrations and mole ratio methods are easy to perform and fast. These methods can be used to determine complexation stoichiometry and formation constants between fluorinecontaining drugs and CD derivatives, provided that the fluorine is embedded into the CD cavity when the complex is formed. For convenient use of this method, the drug must have a relatively high intrinsic solubility so that the acquisition time for each sample is within few minutes. This method could be used to measure enantiomeric composition of chiral compounds, since only very small additions of CD cause separation of peaks in the spectra [25] .
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